US 10851115
Heterocyclic compounds as RSV inhibitors
granted A61PA61P31/16
Quick answer
US patent 10851115 (Heterocyclic compounds as RSV inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P31/16